Publications

All      Ay      Benedict       Cheroutre       Croft       Crotty      Einav       Grifoni       Hogan       Kronenberg      Lisdestam Arlehamn      Myers      Peters      Rao      Reina      Saphire      Schmiedel      Schoenberger      Sette      Sharma      Shresta      Vijayanand      Weiskopf
Altman             Eschweiler      Hedrick       Kawakami      Ley      Pandurangan      Seumois      Von Herrath      
Oct 7, 2019
  • Cancer Immunol Res

Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model

Narayanan JSS, Ray P, Hayashi T, Whisenant TC, Vicente D, Carson DA, Miller AM, Schoenberger SP, White RR
Mar 18, 2019
  • Front Immunol

A threshold model for T-cell activation in the era of checkpoint blockade immunotherapy

Guram K, Kim SS, Wu V, Sanders PD, Patel S, Schoenberger SP, Cohen EEW, Chen SY, Sharabi AB
Jan 1, 2019
  • Cancer Immunol Res

Leveraging TCR affinity in adoptive immunotherapy against shared tumor/self-antigens

Miller AM, Bahmanof M, Zehn D, Cohen EEW, Schoenberger SP
Nov 1, 2018
  • Cold Spring Harb Perspect Biol

Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Targeting the right antigens in the right patients

Schoenberger SP
Oct 10, 2018
  • Front Immunol

Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen

Chiodetti AL, Sánchez Vallecillo MF, Dolina JS, Crespo MI, Marin C, Schoenberger SP, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Morón G, Maletto BA
Jul 21, 2018
  • J Transl Med

Perspectives in melanoma: Meeting report from the melanoma bridge (30 November–2 December, 2017, Naples, Italy)

Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caracò C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M
Apr 3, 2017
  • J Clin Invest

T cells control the generation of nanomolar-affinity anti-glycan antibodies

Polonskaya Z, Deng S, Sarkar A, Kain L, Comellas-Aragones M, McKay CS, Kaczanowska K, Holt M, McBride R, Palomo V, Self KM, Taylor S, Irimia A, Mehta SR, Dan JM, Brigger M, Crotty S, Schoenberger SP, Paulson JC, Wilson IA, Savage PB, Finn MG, Teyton L
Apr 13, 2016
  • Sci Transl Med

The human vaccines project: a roadmap for cancer vaccine development

Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Granoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, Robins H, Sallusto F, Schenkelberg T, Schoenberger S, Sosman J, Türeci Ö, Van den Eynde B, Koff W, Coukos G
May 1, 2015
  • Journal of Immunology

CD28 promotes plasma cell survival, sustained antibody responses and BLIMP-1 upregulation through its distal PYAP proline motif

Rozanski CH, Utley A, Carlson LM, Farren MR, Murray M, Russell LM, Nair JR, Yang Z, Brady W, Garrett-Sinha LA, Schoenberger SP, Green JM, Boise LH, Lee KP
Apr 1, 2015
  • Nature

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U
Feb 1, 2015
  • Immunology and Cell Biology

FoxO3 is a negative regulator of primary CD8+ T-cell expansion but not of memory formation

Togher S, Larange A, Schoenberger SP, Feau S
Jan 1, 2015
  • Nature Medicine

Notch signaling maintains T cell memories

Miller AM, Schoenberger SP